Rihui Cao Selected Research

norharman

1/2012	A series of beta-carboline derivatives inhibit the kinase activity of PLKs.
12/2009	DH166, a beta-carboline derivative, inhibits the kinase activity of PLK1.
8/2007	DH334, a beta-carboline anti-cancer drug, inhibits the CDK activity of budding yeast.
10/2006	Design of beta-carboline derivatives as DNA-targeting antitumor agents.
4/2006	Beta-carboline derivatives: novel photosensitizers that intercalate into DNA to cause direct DNA damage in photodynamic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rihui Cao Research Topics

Disease

4	Neoplasms (Cancer) 01/2012 - 10/2006
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Necrosis 04/2006

Drug/Important Bio-Agent (IBA)

5	norharmanIBA 01/2012 - 04/2006
1	Carbolines (Beta-Carbolines)IBA 01/2021
1	Cyclin B1IBA 12/2009
1	Pharmaceutical PreparationsIBA 08/2007
1	Antineoplastic Agents (Antineoplastics)IBA 10/2006
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2006

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2012
1	Photochemotherapy (Photodynamic Therapy) 04/2006